Major Wall Street bank JPMorgan just cut its price target for Evoke by half—from 66p down to 34p. That's a pretty sharp downgrade. Shows shifting sentiment on the stock's outlook.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.